Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Jacquemin

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 5, 2023
Emicizumab for acquired haemophilia A: A case seriesMatthias M Engelen, Johan Vandesande, Johan De Bent, et al.
Blood|March 30, 2006
FVIII production by human lung microvascular endothelial cellsMarc Jacquemin, Arne Neyrinck, Maria Iris Hermanns, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 11, 2013
Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pumpMotohiko Goda, Steven Jacobs, Filip Rega, et al.
Blood|September 13, 2003
Deletion of alanine 2201 in the FVIII C2 domain results in mild hemophilia A by impairing FVIII binding to VWF and phospholipids and destroys a major FVIII antigenic determinant involved in inhibitor developmentRoseline d'Oiron, Jean-Maurice Lavergne, Renaud Lavend'homme, et al.
Blood|May 17, 2017
Frequency and epitope specificity of anti-factor VIII C1 domain antibodies in acquired and congenital hemophilia AJoerg Kahle, Aleksander Orlowski, Diana Stichel, et al.
JHLT Open|January 16, 2026
Thrombin generation in HeartMate 3 patients on apixaban and vitamin K antagonists: Variability limits clinical applicabilityCharlotte J Van Edom, Walter Droogné, Steven Jacobs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2009
In vivo induction of type 1-like regulatory T cells using genetically modified B cells confers long-term IL-10-dependent antigen-specific unresponsivenessRoxana Roohi Ahangarani, Wim Janssens, Luc VanderElst, et al.
Therapeutic Advances in Hematology|June 26, 2025
Acquired von Willebrand syndrome secondary to monoclonal gammopathy: a single-center case seriesQuentin Van Thillo, Finn Segers, Jan Brijs, et al.
Transplantation|March 23, 2021
Coagulation Factors Accumulate During Normothermic Liver Machine Perfusion Regardless of Donor Type and Severity of Ischemic InjuryNicholas Gilbo, Marc Jacquemin, David Nasralla, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Clinical application of multigene panel testing for bleeding, thrombotic, and platelet disorders: a 3-year Belgian experienceChristine Van Laer, Marc Jacquemin, Sarissa Baert, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 5, 2023
Emicizumab for acquired haemophilia A: A case seriesMatthias M Engelen, Johan Vandesande, Johan De Bent, et al.
Blood|March 30, 2006
FVIII production by human lung microvascular endothelial cellsMarc Jacquemin, Arne Neyrinck, Maria Iris Hermanns, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 11, 2013
Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pumpMotohiko Goda, Steven Jacobs, Filip Rega, et al.
Blood|September 13, 2003
Deletion of alanine 2201 in the FVIII C2 domain results in mild hemophilia A by impairing FVIII binding to VWF and phospholipids and destroys a major FVIII antigenic determinant involved in inhibitor developmentRoseline d'Oiron, Jean-Maurice Lavergne, Renaud Lavend'homme, et al.
Blood|May 17, 2017
Frequency and epitope specificity of anti-factor VIII C1 domain antibodies in acquired and congenital hemophilia AJoerg Kahle, Aleksander Orlowski, Diana Stichel, et al.
JHLT Open|January 16, 2026
Thrombin generation in HeartMate 3 patients on apixaban and vitamin K antagonists: Variability limits clinical applicabilityCharlotte J Van Edom, Walter Droogné, Steven Jacobs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2009
In vivo induction of type 1-like regulatory T cells using genetically modified B cells confers long-term IL-10-dependent antigen-specific unresponsivenessRoxana Roohi Ahangarani, Wim Janssens, Luc VanderElst, et al.
Therapeutic Advances in Hematology|June 26, 2025
Acquired von Willebrand syndrome secondary to monoclonal gammopathy: a single-center case seriesQuentin Van Thillo, Finn Segers, Jan Brijs, et al.
Transplantation|March 23, 2021
Coagulation Factors Accumulate During Normothermic Liver Machine Perfusion Regardless of Donor Type and Severity of Ischemic InjuryNicholas Gilbo, Marc Jacquemin, David Nasralla, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Clinical application of multigene panel testing for bleeding, thrombotic, and platelet disorders: a 3-year Belgian experienceChristine Van Laer, Marc Jacquemin, Sarissa Baert, et al.
Pageof 6